Skip to content
Screener

Mannkind MNKD Shares (Diluted)

Shares (Diluted) at other companies

Eli Lilly logo
Eli LillyLLY
893.7M-0.7%
LQD
Liquidia CorporationLQDA
101.1M+18.7%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
437.7M+20.4%
Omada Health logo
Omada HealthOMDA
63.9M+191%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
82.8M+55.8%
Viking Therapeutics logo
Viking TherapeuticsVKTX
115.6M+3.1%

Other financials

Income statement

See full
Revenue$109.4M+42.9%
Gross profit$95.0M+32.0%
Operating income-$350.0K-107%
Net income-$19.0M-2,949%
EPS (diluted)-$0.06

Balance sheet

See full
Cash & equivalents$52.9M-7.2%
Total debt$11.8M-7.5%
Total equity-$67.2M-22.1%
Total assets$732.3M+77.9%

Cash flow

See full
Operating cash flow-$18.4M-305%
CapEx$5.1M+355%
Free cash flow-$23.5M-399%

Valuation

See full
Market cap$1.25B+17.8%
Enterprise value$1.21B+18.9%
P/S3.2×-0.3×

Profitability

See full
Gross margin89.8%-4.8pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity44.2%
Debt / equity-0.2×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Mannkind’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335054
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total other expense(18,788)(4,359)(33,486)(13,035)
(Loss) income before income tax (benefit) expense(19,138)940(35,504)14,557
Income tax (benefit) expense(106)272147731
Net (loss) income$(19,032)$668$(35,651)$13,826
Net (loss) income per share – basic$(0.06)$0.00$(0.12)$0.05
Weighted average shares used to compute net (loss) income per share – basic309,191304,954308,732304,222
Net (loss) income per share – diluted$(0.06)$0.00$(0.12)$0.04
Weighted average shares used to compute net (loss) income per share – diluted309,191311,484308,732312,381

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Mannkind's shares (diluted)?
Mannkind (MNKD) reported shares (diluted) of 309.2M in Q2 2026.
How has Mannkind's shares (diluted) changed year-over-year?
Mannkind's shares (diluted) decreased by 0.7% year-over-year, from 311.5M to 309.2M.
What is the long-term trend for Mannkind's shares (diluted)?
Over 4 years (2021 to 2025), Mannkind's shares (diluted) has grown at a 6.0% compound annual growth rate (CAGR), from 995.1M to 1.3B.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Mannkind's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude